Utilising disease heterogeneity and emerging biomarkers to individualise prostate treatment
Utilising disease heterogeneity and emerging biomarkers to individualise prostate treatment
What is the link between mechanobiology and cancer?
How does your garden grow? For cancer patients, small gardens could bring big benefits
Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following cystectomy for bladder cancer
Molecular genetics of testicular cancer: What does the clinician need to know?
Atezolizumab for platinum-treated locally advanced or metastatic urothelial carcinoma
Healthcare and QoL burden of symptomatic skeletal events in CRPC with bone mets
Regular aspirin use may reduce risk of dying from prostate cancer
Brentuximab vedotin as salvage therapy for men with relapsed germ-cell tumours
Actionable targets in patients with cisplatin-resistant advanced germ cell tumours
Post-translational modification (PTM) profiling – a novel tool for mapping the PTM landscape in cancer
Medical cancer prevention